Finance
Finance
Sterling Slumps as Oil's Surge to $120 on Iran War Rocks Markets
Finance
Roche Shares Drop as Oral Breast Cancer Drug Fails in Trial
Finance
Euro Zone Bonds Slump as Middle East War Spurs Oil Price Spike, Stoking Market Jitters
Finance
German Submarine Systems Maker Gabler Rises in Stock Market Debut
Dreamcatcher Finance Named Best Auto Finance Company Australia 2026 by Global Banking & Finance Review®
Date: March 9, 2026
Global Banking & Finance Review® is pleased to announce that Dreamcatcher Finance has been honoured with the prestigious Best Auto Finance Company Australia 2026 award at the Global Banking & Finance Review Awards®....
Nvidia-Backed UK AI Firm Nscale Raises $2 Billion in Funding Round
Date: March 9, 2026
BENGALURU, March 9 (Reuters) - Nvidia-backed British artificial intelligence group Nscale has raised $2 billion at a valuation of $14.6 billion, the company said on Monday. (Reporting by Ruchika...
Shipping Services Firm Clarksons' Annual Profit Drops on Market Uncertainty
Date: March 9, 2026
March 9 (Reuters) - Clarksons, the world’s largest shipping services provider, posted a 21% drop in its annual profit on Monday, as geopolitical uncertainty and U.S. tariffs weighed on its broking and...
Governments Scramble to Limit Fallout of Iran War as Oil Prices Surge
Date: March 9, 2026
SINGAPORE, March 9 (Reuters) - Governments scrambled to limit the impact on economies and consumers from the widening Iran war, which fuelled a record surge in oil prices on Monday after key producers...
Synagogue in Belgian City of Liege Damaged in Explosion, Vrt Reports
Date: March 9, 2026
March 9 (Reuters) - A synagogue in the Belgian city of Liege was damaged by an explosion early on Monday, Belgian broadcaster VRT reported, citing local police. No injuries were reported. The cause of...
Gsk Licenses Liver Disease Drug to Italy's Alfasigma for up to $690 Million
Date: March 9, 2026
March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutical company Alfasigma for the worldwide rights to linerixibat, an experimental treatment for severe...